LIMN · Liminatus Pharma, Inc.
$0.11
-0.01 (-6.57%)
At close · Jul 24
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has concluded that there is substantial doubt about its ability to continue as a going concern for one year after the date that the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 15, 2026
Market Cap
$4.98M
Shares
44.88M
Liminatus Pharma, Inc. Earnings Call Transcripts
Every quarterly earnings call for Liminatus Pharma, Inc. (LIMN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
No Earnings Calls Available
No earnings call events are available for this stock yet.
Key facts
CIK
1971387
CUSIP
53271X108
13F (30d)
3 filings
3 filers